Cargando…
CD36 Signal Transduction in Metabolic Diseases: Novel Insights and Therapeutic Targeting
The cluster of differentiation 36 (CD36) is a scavenger receptor present on various types of cells and has multiple biological functions that may be important in inflammation and in the pathogenesis of metabolic diseases, including diabetes. Here, we consider recent insights into how the CD36 respon...
Autores principales: | Karunakaran, Udayakumar, Elumalai, Suma, Moon, Jun-Sung, Won, Kyu-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305429/ https://www.ncbi.nlm.nih.gov/pubmed/34360006 http://dx.doi.org/10.3390/cells10071833 |
Ejemplares similares
-
Ferroptosis Signaling in Pancreatic β-Cells: Novel Insights & Therapeutic Targeting
por: Elumalai, Suma, et al.
Publicado: (2022) -
Rac1-NADPH oxidase signaling promotes CD36 activation under glucotoxic conditions in pancreatic beta cells
por: Elumalai, Suma, et al.
Publicado: (2016) -
The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond
por: Moon, Jun Sung, et al.
Publicado: (2020) -
NADPH Oxidase (NOX) Targeting in Diabetes: A Special Emphasis on Pancreatic β-Cell Dysfunction
por: Elumalai, Suma, et al.
Publicado: (2021) -
Pioglitazone-induced AMPK-Glutaminase-1 prevents high glucose-induced pancreatic β-cell dysfunction by glutathione antioxidant system
por: Karunakaran, Udayakumar, et al.
Publicado: (2021)